Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1248 |
|
| Actual shortage: | 54 (4%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1158 (93%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
208 (14%) |
|
Overdue reports |
8 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-16 | 2019-06-29 | 72629 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-16 | 2021-10-15 | 72632 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-04 | 2019-09-12 | 77490 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-29 | 2019-09-12 | 79850 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-09-12 | 2021-10-15 | 93825 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-15 | 2021-10-15 | 98823 |
| PMS-CARBAMAZEPINE-CR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-05-07 | 2021-04-23 | 114174 |
| PMS-OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-11-15 | 2021-12-06 | 149257 |
| PMS-FAMPRIDINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-09-16 | 2022-12-09 | 169462 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-11 | 2023-02-07 | 174393 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-10 | 2023-08-11 | 198000 |
| PMS-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2023-07-10 | 2023-09-18 | 198022 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-11-30 | 2024-02-28 | 211901 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-12-27 | 2024-02-28 | 214316 |
| PMS-CIPROFLOXACIN XL | 500MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-06-09 | 2024-05-10 | 194525 |
| PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6337 |
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6340 |
| PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6343 |
| PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6346 |
| PMS-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-18 | 2018-12-12 | 10674 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118153 |
| PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118156 |
| PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118159 |
| PMS-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-07-25 | 2022-07-25 | 165469 |